Skip to main content
. 2019 Oct 11;11(10):2424. doi: 10.3390/nu11102424
ID iron deficiency IDA Iron-deficiency anaemia
GBD Global Burden of Disease CKD chronic kidney disease
ACD Anemia of Chronic Disease IBD inflammatory bowel disease
IV intravenous EPO erythropoietin
ESA erythropoietin stimulating agent rHuEPO recombinant human erythropoietin
FPN ferroportin DMT1 divalent metal transporter
Dcytb duodenal cytochrome b MCV mean corpuscular volume
Hb haemoglobin BMP bone morphogenic protein
HJV hemojuvelin SMAD Mothers Against Decapentaplegic
JAK2 Janus kinase 2 STAT 3 Signal transducer and activator of transcription 3
GDF 15 growth differentiation factor 15 PDGF-BB platelet-derived growth factor-BB
HIF hypoxia-inducible factor VEGF vascular endothelial growth factor
IL Interleukin FCF23 fibroblast growth factor
KDIGO Kidney Disease: Improving Global Outcomes CHOIR Correction of Haemoglobin and Outcomes in Renal Insufficiency
CREATE Cardiovascular Risk Reduction by Early Anemia Treatment TREAT Trial to Reduce Cardiovascular Events with Aranesp
HIF-PHDI Hypoxia-Inducible factor Prolyl Hydroxylase Inhibitor